Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.BioCryst begins proof of concept trial in PNH patients with oral Factor D inhibitor, BCX9930
BioCryst begins proof of concept trial in PNH patients with oral Factor D inhibitor, BCX9930. (Credit: PublicDomainPictures from Pixabay)
BioCryst begins proof of concept trial in PNH patients with oral Factor D inhibitor, BCX9930. (Credit: PublicDomainPictures from Pixabay)